Pharmafile Logo
Pharmafocus logo
Advanced Search

Teva

Showing 15 posts of 234 posts found.

Pfizer picture

Pfizer recalls oral contraceptive for packaging errors

February 2, 2012
Manufacturing and Production Akrimax, Bedford, Cephalon, Lo/Ovral-28, Pfizer, Teva

Pfizer has been forced to recall a large volume of oral contraceptive packs distributed in the US market because a …

News

Yanai steps down as Teva’s chief executive after four years at the helm

January 3, 2012
Medical Communications Teva

Shlomo Yanai is to step down as the chief executive and president of Teva, the world’s biggest generic drug makers. …

Appointment
Teva picture

Teva gains tentative approval to sell generic Lipitor in 2012

December 5, 2011
Sales and Marketing Lipitor, Pfizer, Ranbaxy, Teva

Teva has gained a tentative approval by the FDA to sell its generic form of Pfizer’s blockbuster statin Lipitor next …

News

FDA approves Ranbaxy’s generic Lipitor

December 1, 2011
Manufacturing and Production, Sales and Marketing Lipitor, Pfizer, Ranbaxy, Teva

The FDA will allow Ranbaxy to develop a generic version of Pfizer’s blockbuster statin Lipitor. The firm has received final …

News
dipankar_bhattacharjee_teva

Dipankar Bhattacharjee becomes vice president of Teva Northern Europe

November 21, 2011
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Teva

Dipankar Bhattacharjee has been promoted to vice president of UK and Teva Northern Europe. Teva said that as part of …

Appointment
Ranbayx image

Ranbaxy to collaborate with Teva on generic Lipitor in US?

November 7, 2011
Manufacturing and Production, Sales and Marketing Lipitor, Pfizer, Ranbaxy, Teva

Israeli drugmaker Teva Pharmaceutical could get an unexpected boost from an earlier-than-expected launch of its generic version of Pfizer’s cholesterol …

News
e

Teva sees modest growth as US sales fall

November 3, 2011
Business Services, Sales and Marketing Teva, generics

Sales growth at Teva was modest in Q3, rising 2% to $4.34 billion, with growth predominately coming from branded drugs.This …

News

Teva makes commitment to Russian manufacturing facility

September 20, 2011
Manufacturing and Production, Sales and Marketing Russia, Teva

Teva has joined a number of its peers in the pharmaceutical sector and announced plans to build a new manufacturing …

News

Teva in the dock again for hepatitis link to propofol

August 30, 2011
Manufacturing and Production Teva, manufacturing and production news, propofol

Teva’s decision to shut down a manufacturing facility for the anaesthetic propofol has become a focal point in a US …

News

Teva’s MS treatment disappoints

August 2, 2011
Research and Development, Sales and Marketing Laquinimod, MS, Teva

Teva and Active Biotech’s oral MS drug laquinimod has failed to meet its primary endpoint in a phase III trial. …

News

Teva closes one Canadian plant, expands two more

July 22, 2011
Manufacturing and Production Canada, Teva

Teva Pharmaceutical has decided to shut down its recently-acquired manufacturing Canadian facility in Montreal, Quebec, having failed to find a …

News
Cephalon

Teva’s Cephalon acquisition could be delayed

June 15, 2011
Manufacturing and Production, Research and Development, Sales and Marketing Cephalon, Teva

The Federal Trade Commission has requested more information about Teva’s deal with Cephalon, potentially delaying the purchase by a month. …

News

Teva plans Japan expansion with Taiyo buy

May 17, 2011
Sales and Marketing Taiyo, Teva, generics

Teva is to acquire a majority stake in Taiyo, Japan’s third largest generics company for $460 million in cash. The …

News

Generic and API firms get latest crop of FDA warning letters

May 10, 2011
Manufacturing and Production Cephazone, FDA, FDA warning letter, Ningbo Smart, Teva

Generic drugmakers Teva and Cephazone and API producer Ningbo Smart are the latest companies to receive warning letters from the …

News
Cephalon

Cephalon accepts Teva’s $6.8 billion white knight bid

May 3, 2011
Research and Development, Sales and Marketing Cephalon, Teva, Valeant, generics

Generics giant Teva has acquired Cephalon for $6.8 billion and says the deal will make it a leading specialty pharmaceutical …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026